Tumors on Ice as Budget Impasse Freezes Medical Research

Tumors on Ice as Budget Impasse Freezes Medical Research

Peter Foley/Bloomberg

Sequestration, the automatic, across-the-board spending reductions triggered last month after U.S. lawmakers failed to agree on a debt strategy, has cast a shadow of uncertainty over public funding for medical research. That work often serves as the basis for new treatments and strategies from drugmakers such as Pfizer Inc. and device makers such as Johnson & Johnson.